Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis

A. S. Paller*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis'. Together they form a unique fingerprint.